METTL1 and central nervous system cancer: In this study, the differences in the expression of METTL1 between carcinoma and paracancer cells of glioma were analyzed by bioinformatics, PCR, and immunohistochemistry experiments. METTL1 was knocked down in vitro for functional and pathway analysis.